ESR1 and breast cancer: Breast cancer is the most common malignant cancer among women (Bao et al., 2019), and approximately 70% of breast cancer patients are estrogen receptor-positive (ER+) (Jemal et al., 2011; Cai et al., 2018; Mitobe et al., 2020).